Evidence map›Paper›PMID 36160450›Full record

ReviewFrontiers in pharmacology2022

The critical role of ferritinophagy in human disease.

Meng-Zhen Liu, Ni Kong, Guang-Yu Zhang, Qin Xu, Yang Xu, Ping Ke, Chong Liu

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Oxidative Stress andInternational journal of molecular sciences · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. The geroprotective potential of chalcones.Nature communications · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meng-Zhen LiuDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Ni KongDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Guang-Yu ZhangDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Qin XuDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Yang XuDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Ping KeDepartment of Pharmacy, Second Military Medical University, Shanghai, China.
Chong LiuDepartment of Pharmacy, Second Military Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferritinophagy is a type of autophagy mediated by nuclear receptor activator 4 (NCOA4), which plays a role in inducing ferroptosis by regulating iron homeostasis and producing reactive oxygen species in cells. Under physiological conditions, ferritinophagy maintains the stability of intracellular iron by regulating the release of free iron. Studies have demonstrated that ferritinophagy is necessary to induce ferroptosis; however, under pathological conditions, excessive ferritinophagy results in the release of free iron in large quantities, which leads to lipid peroxidation and iron-dependent cell death, known as ferroptosis. Ferritinophagy has become an area of interest in recent years. We here in review the mechanism of ferritinophagy and its association with ferroptosis and various diseases to provide a reference for future clinical and scientific studies.

Indexed as

ferritinophagyferroptosisheme degradationiron homeostasisNCOA4

Identifiers

PMID36160450
PMCPMC9493325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.